**Amgen: A Pharmaceutical Leader Continues to Thrive**

In the latest Fortune 2024 ranking, Amgen has secured the 151st position, reflecting the company's continued growth and success within the pharmaceutical industry. As a prominent player in the health care sector, Amgen has demonstrated its ability to adapt and evolve in a rapidly changing market.

With a market value of $152,372.5 million as of March 28, 2024, Amgen boasts an impressive market capitalization, solidifying its position as a major player in the industry. The company's revenue has also shown a notable increase, with a 7.1% year-over-year growth, reaching $28,190.0 million. This upward trend is a testament to Amgen's commitment to innovation and its ability to meet the evolving needs of the market.

In terms of profitability, Amgen has maintained a strong performance, with profits of $6,717.0 million, representing a 2.5% increase from the previous year. The company's asset base has also expanded, reaching $97,154.0 million, further solidifying its financial stability.

Under the leadership of CEO Robert A. Bradway, Amgen continues to prioritize growth and innovation. The company's growth in jobs is a positive indicator of its commitment to expanding its workforce and investing in its human capital. With a total of 26,700 employees, Amgen remains a significant employer in the industry.

Amgen's ranking has shown a notable improvement, with a 3.0 position gain in the full Fortune 1000 list. This upward movement is a testament to the company's ability to adapt to changing market conditions and maintain its competitive edge.

As a U.S.-based company, Amgen is headquartered in Thousand Oaks, California, and is listed as a public company. The company's website, www.amgen.com, provides a wealth of information on its products, services, and corporate initiatives.

Amgen's inclusion in the World's Most Admired Companies list is a notable recognition of its commitment to excellence and its reputation as a leader in the pharmaceutical industry. While the company did not make the cut for the Best Companies to Work For list, its growth in jobs and employee base suggest a positive work environment and a commitment to its human capital.

In conclusion, Amgen's performance in the Fortune 2024 ranking is a testament to its strength and resilience in the pharmaceutical industry. With a strong financial performance, a growing workforce, and a commitment to innovation, Amgen is well-positioned to continue its upward trajectory in the years to come.